ANI Pharma (ANIP) Announces Proposed Stock Offering, Size not Disclosed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
ANI Pharma (ANIP) Prices 1.5M Share IPO at $50/sh
November 4, 2021 5:36 AM EDTANI Pharmaceuticals, Inc. (NASDAQ: ANIP) today announced the pricing of an underwritten public offering of 1,500,000 shares of its common stock at a public offering price of $50.00 per share. The gross proceeds of the offering to the Company are expected to be $75 million, before deducting the underwriting discounts and commissions and other offering expenses. In addition, ANI granted the underwriters a 30-day option to purchase up to an additional 225,000 shares of common stock at the public offering price, less underwriting discounts and commissions.
The... More
Truist Securities Starts ANI Pharmaceuticals (ANIP) at Buy
November 2, 2021 6:06 AM EDTTruist Securities analyst Gregory Fraser initiates coverage on ANI Pharmaceuticals (NASDAQ: ANIP) with a Buy rating and a price target of $70.00.
For an analyst ratings summary and ratings history on ANI Pharmaceuticals click here. For more ratings news on ANI Pharmaceuticals click here.
Shares of ANI Pharmaceuticals closed at $55.89 yesterday.
... MorePre-Open Stock Movers 11/01: (ANIP) (LDI) (HOG) Higher; (BTBT) (TRIP) (CRWD) Lower (more...)
November 1, 2021 9:29 AM EDTPre-Open Stock Movers:
Bit Digital, Inc. (NASDAQ: BTBT) 17% LOWER; gives back some of Friday's late-day surge.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) 15.5% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has approved the Companys supplemental New Drug Application (sNDA) for Purified Cortrophin Gel (Repository Corticotropin Injection USP) (Cortrophin Gel) for the treatment of certain chronic autoimmune disorders, including acute exacerbations of multiple sclerosis (MS) and rheumatoid arthritis (RA), in addition to excess urinary protein due... More
ANI Pharma (ANIP) Reports Q3 Loss of $0.37/sh
November 1, 2021 6:48 AM EDTANI Pharma (NASDAQ: ANIP) reported Q3 EPS of ($0.37), versus $0.04 reported last year. Revenue for the quarter came in at $52.1 million, versus $52.98 million reported last year.
For earnings history and earnings-related data on ANI Pharma (ANIP) click here.
... More